• Ultima, NVIDIA, Google Partner on Pangenome-Aware Whole Genome Sequencing

    Bio-IT World | Ultima Genomics and NVIDIA are collaborating to enable pangenome-aware whole genome sequencing (WGS) analysis, combining Ultima’s high-output, cost-efficient sequencing platform with accelerated GPU-enhanced computational approaches from NVIDIA and Google’s open source DeepVariant for pangenome graph alignment and variant calling. The collaboration aims to make pangenome-aware WGS variant calling practical.

    Sep 9, 2026

  • Clearing the Bench-To-Bedside Hurdle: Why Translational Medicine Needs to Start Earlier

    Bio-IT World | There’s an enormous graveyard for medical innovations that showed tremendous promise in the lab yet stalled out in early clinical trials and never reached patients at scale. We've largely come to accept this high failure rate as an inevitable reality of translational medicine. But over the past 17 years developing an implantable ultrasound platform for blood-brain barrier modulation, I've come to a different conclusion: we're asking translational medicine to solve problems that should have been addressed much earlier in development.

    Sep 4, 2026

  • NVIDIA Acquires Hugging Face for $12.93 Billion

    Bio-IT World This morning NVIDIA announced its agreement to acquire Hugging Face for $12.93 billion. The two groups plan to scale Hugging Face’s platform, strengthen its infrastructure and expand access to AI for developers and institutions worldwide.

    Sep 3, 2026

  • Deep-Learning Tool Uses Long-Read Sequencing to Detect Cancer Mutations

    Bio-IT World | Analyzing genetic changes in cancer cells can provide insight into how tumors develop and inform precision oncology. However, identifying cancer-related mutations can be challenging, particularly when they occur at low frequencies or in complex regions of the genome. Researchers at The University of Hong Kong have developed ClairS, a tool designed to detect small cancer-related genetic mutations from long-read sequencing data.

    Sep 2, 2026

  • Trends from the Trenches: Rethinking Computational Workflows for Modern Genomics

    Bio-IT World | Modern genomics and precision medicine are generating data at a scale that is challenging traditional bioinformatics workflows. As researchers increasingly combine genomic data with phenotype, transcriptomics, proteomics, and imaging, they face growing demands for reproducible pipelines, standardized methods, and collaboration across laboratories, hospitals, and biobanks. In the latest episode of Trends from the Trenches, Ben Busby, global alliance manager for omics at NVIDIA, argues that addressing those challenges requires a shift in how scientists approach computational research.

    Sep 1, 2026

  • Trends from the Trenches: Rethinking Computational Workflows for Modern Genomics

    Bio-IT World | Modern genomics and precision medicine are generating data at a scale that is challenging traditional bioinformatics workflows. As researchers increasingly combine genomic data with phenotype, transcriptomics, proteomics, and imaging, they face growing demands for reproducible pipelines, standardized methods, and collaboration across laboratories, hospitals, and biobanks. In the latest episode of Trends from the Trenches, Ben Busby, global alliance manager for omics at NVIDIA, argues that addressing those challenges requires a shift in how scientists approach computational research.

    Sep 1, 2026

  • What Scientists Actually Need From AI

    Bio-IT World | A target looks good on paper. The literature supports it, the mechanism is plausible, and three independent groups have published findings that point the same direction. There is also a contradictory result, which someone found early, mentioned in a meeting, and set aside because it seemed less persuasive than the rest. The team builds its case, and the program advances. Years later, in preclinical validation or, worse, in the clinic, that discarded finding turns out to have been the important one.

    Aug 28, 2026

  • Follow the Money: Biological Foundation Models, Automated Bioanalysis, Predictive Cancer Care

    Bio-IT World | LifeMine Therapeutics advances a novel treatment for organ transplantation; InduPro doses the first patient in a phase 1 study of a bispecific antibody-drug conjugate; Remepy advances an AI-enabled treatment for Parkinson’s disease; and more.

    Aug 26, 2026